Overview

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
A phase I trial to determine the recommended phase two dose of the combination of carboplatin and olaparib.
Phase:
Phase 1
Details
Lead Sponsor:
The Netherlands Cancer Institute
Treatments:
Carboplatin
Olaparib